An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults (pages 66–73)Kawsar R. Talaat, Ruth A. Karron, Philana H. Liang, Bridget A. McMahon, Catherine J. Luke, Bhagvanji Thumar, Grace L. Chen, Ji-Young Min, Elaine W. Lamirande, Hong Jin, Kathy L. Coelingh, George W. Kemble and Kanta Subbarao
Article first published online: 14 MAR 2012 | DOI: 10.1111/j.1750-2659.2012.00350.x